that would involve getting pricked with a needle at your local Quest Diagnostics. It sounds a bit antiquated, doesn’t it? These days, you can order a home test for everything from colon cancer ...

That doctor might, or might not, order further testing for you—a blood panel, say, that would involve getting pricked with a needle at your local Quest Diagnostics. It sounds a bit antiquated, doesn’t ...

A Chantilly office and laboratory facility anchored by Quest Diagnostics traded hands in October for nearly three times its ...

Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian ...

Oct 23 - Lab operator Quest Diagnostics (DGX.N), opens new tab said on Wednesday it will launch a test for H5N1 bird flu at ...

Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS. Read why I ...

Quest Diagnostics reports strong Q3 with 8.5% sales growth, raises 2024 revenue guidance to $9.80 billion-$9.85 billion, citing acquisitions and new customer wins.

Leerink Partners analyst Michael Cherny has reiterated their neutral stance on DGX stock, giving a Hold rating yesterday. Michael Cherny has ...

(RTTNews) - Quest Diagnostics (DGX) announced Monday that ... in Ohio will benefit from access to Quest's industry-leading test menu, network of patient service sites, broad health plan coverage ...